0001574774-20-000045.txt : 20200506 0001574774-20-000045.hdr.sgml : 20200506 20200506161858 ACCESSION NUMBER: 0001574774-20-000045 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 18 CONFORMED PERIOD OF REPORT: 20200506 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20200506 DATE AS OF CHANGE: 20200506 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIOTELEMETRY, INC. CENTRAL INDEX KEY: 0001574774 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093] IRS NUMBER: 462568498 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-55039 FILM NUMBER: 20852870 BUSINESS ADDRESS: STREET 1: 1000 CEDAR HOLLOW ROAD CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: 610-729-7000 MAIL ADDRESS: STREET 1: 1000 CEDAR HOLLOW ROAD CITY: MALVERN STATE: PA ZIP: 19355 FORMER COMPANY: FORMER CONFORMED NAME: BioTelemetry, Inc. DATE OF NAME CHANGE: 20130418 8-K 1 beat56208k.htm 8-K Document
false0001574774 0001574774 2020-05-06 2020-05-06


 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): May 6, 2020
logo1a05.jpg
BioTelemetry, Inc.
(Exact name of registrant as specified in its charter)
 
Delaware
 
000-55039
 
46-2568498
(State or other jurisdiction
 
(Commission
 
(IRS Employer
of incorporation)
 
File Number)
 
Identification No.)
 
1000 Cedar Hollow Road
 
 
Malvern,
Pennsylvania
 
19355
(Address of principal executive offices)
 
(Zip Code)

Registrant’s telephone number, including area code: (610) 729-7000

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, par value $0.001 per share
BEAT
NASDAQ Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 





Item 2.02 Results of Operations and Financial Condition.
On May 6, 2020, BioTelemetry, Inc. issued a press release announcing its financial results for the first quarter ended March 31, 2020. Such information, including the Exhibit attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing. A copy of the press release is included herewith as Exhibit 99.1.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit Number
 
Exhibit Title
 
104
 
Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
 
BioTelemetry, Inc.
 
 
 
 
 
 
 
 
Date: May 6, 2020
 
By:
/s/ Heather C. Getz
 
 
 
 
 
 
 
Name:
Heather C. Getz
 
 
 
Title:
Executive Vice President, Chief Financial and Administrative Officer



 EX-99.1 2 beat56208kex991.htm EXHIBIT 99.1 Exhibit
Exhibit 99.1

beatlogoa08.jpg

BioTelemetry, Inc. Reports First Quarter 2020 Financial Results
Announces Record Quarterly Revenue

Malvern, PA – May 6, 2020 – BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today reported results for the quarter ended March 31, 2020.

Quarter Highlights

•
Recognized quarterly revenue of $113.0 million
•
Reached 8.7% year-over-year quarterly revenue growth
•
Achieved 31st consecutive quarter of year-over-year revenue growth
•
Reported quarterly GAAP net income of $7.1 million, or 6.3% of revenue
•
Realized quarterly adjusted EBITDA of $29.5 million, or 26.1% of revenue


President and CEO Commentary

Joseph H. Capper, President and Chief Executive Officer of BioTelemetry, Inc., commented:

“I would like to first express my sincere gratitude to the entire BioTelemetry team and to our many customers, suppliers and partners for their unwavering commitment in providing continuous service as we navigate this crisis.

“In spite of the current challenges, we had an excellent first quarter, during which we grew revenue to a record high of $113.0 million and recorded $29.5 million of adjusted EBITDA. All segments of the business grew and contributed to our 31st consecutive quarter with year-over-year revenue growth.

“When the crisis hit, we made the necessary adjustments to scale back our operating cost structure without dramatically changing our capabilities. Our focus now is to guide the Company through this crisis as efficiently and effectively as possible, while remaining well positioned to meet demand in the event of a rapid recovery. Our excellent financial position will also enable us to continue advancing our business development opportunities.

“In a post-COVID healthcare environment, there will certainly be a greater acceptance of tele-health and remote monitoring solutions. As one of the largest, fastest growing and most profitable connected health companies, we are fortunate to be well ahead of the demand curve and perfectly positioned to capitalize on this opportunity.”

beatlogoa07.jpg

First Quarter Financial Results

Revenue for the first quarter 2020 was $113.0 million compared to $104.0 million for the first quarter 2019, an increase of $9.1 million, or 8.7%.

Gross profit for the first quarter 2020 was $70.5 million, or 62.4% of revenue, compared to $64.8 million, or 62.3% of revenue, for the first quarter 2019.

On a GAAP basis, net income for the first quarter 2020 was $7.1 million, or $0.19 per diluted share, compared to net income of $11.7 million, or $0.32 per diluted share, for the first quarter 2019. The decline in net income was primarily due to an increase in income tax expense, driven by the higher equity compensation deductions in the prior year as compared to the current period.

On an adjusted basis1, net income for the first quarter 2020 was $16.4 million, or $0.45 per diluted share. This compares to adjusted net income of $15.2 million, or $0.42 per diluted share, for the first quarter 2019. Revenue growth is being offset by the impact of the ongoing investments in our sales force and technology. The details regarding adjusted net income are included in the reconciliation tables included in this release.

1 The Company believes that providing non-GAAP financial measures offers a meaningful representation of our performance, as we exclude expenses that are not necessary to support our ongoing business. We also make adjustments to facilitate year over year comparisons. Please refer to our “Reconciliation of GAAP to Non-GAAP Financial Measures” in this release for additional information.

2020 Guidance

In view of the COVID-19 pandemic, BioTelemetry is withdrawing its previous financial guidance issued on February 26, 2020.  Given the uncertain scope and duration of the pandemic, BioTelemetry is unable to estimate the impact of the COVID-19 outbreak on its operations and financial results.

Conference Call

BioTelemetry, Inc. will host an earnings conference call on Wednesday, May 6, 2020, at 5:00 PM Eastern Time. The call will be webcast on the investor information page of our website, www.gobio.com/investors/events. The call will be archived on our website for two weeks.

About BioTelemetry

BioTelemetry, Inc. is the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care. We provide remote cardiac monitoring, centralized core laboratory services for clinical trials, remote blood glucose monitoring and original equipment manufacturing that serves both healthcare and clinical research customers. More information can be found at www.gobio.com.

Cautionary Statement Regarding Forward-Looking Statements

This document includes certain forward-looking statements within the meaning of the “Safe Harbor” provisions of the Private Securities Litigation Reform Act of 1995 regarding, among other things, our growth prospects, the prospects for our products and our confidence in our future. These statements may be identified by words such as “expect,” “anticipate,” “estimate,” “intend,” “plan,” “believe,” “promises” and other words and terms of similar meaning. Examples of forward-looking statements include statements we make regarding the successful execution of our operating plan, our ability to increase

beatlogoa07.jpg

demand for our products and services, to grow our market share and to recover from the impacts of the COVID-19 pandemic, our expectations regarding revenue trends in our segments, and our growth expectations for 2020. Such forward-looking statements are based on current expectations and involve inherent risks and uncertainties, including important factors that could delay, divert or change any of these expectations, and could cause actual outcomes and results to differ materially from current expectations. These factors include, among other things: our ability to identify acquisition candidates, acquire them on attractive terms and integrate their operations into our business; our ability to educate physicians and continue to obtain prescriptions for our products and services; changes to insurance coverage and reimbursement levels by Medicare and commercial payors for our products and services; our ability to attract and retain talented executive management and sales personnel; the commercialization of new competitive products; acceptance of our new products and services, such as our mobile cardiac telemetry patch; the impact of the COVID-19 pandemic; the impact of the October 2019 information technology incident; our ability to obtain and maintain required regulatory approvals for our products, services and manufacturing facilities; changes in governmental regulations and legislation; adverse regulatory actions; our ability to obtain and maintain adequate protection of our intellectual property; interruptions or delays in the telecommunications systems and/or information technology systems that we use; our ability to successfully resolve outstanding legal proceedings; and the other factors that are described in “Part I; Item 1A. Risk Factors” of our Annual Report on Form 10-K for the year ended December 31, 2019, as well as the factors that are described in “Part II; Item 1A. Risk Factors” of our Quarterly Report on Form 10-Q for the quarter ended March 31, 2020.

We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise, except as may be required by law.

Contact:     BioTelemetry, Inc.
Heather C. Getz
Executive Vice President, Chief Financial and Administrative Officer
800-908-7103
investorrelations@gobio.com


beatlogoa07.jpg

BioTelemetry, Inc.
Consolidated Statements of Operations
(unaudited)
 
Three Months Ended
 
March 31,
(in thousands, except per share data)
2020
 
2019
Revenue
$
113,031

 
$
103,979

Cost of revenue
42,523

 
39,201

Gross profit
70,508

 
64,778

Gross profit %
62.4
%
 
62.3
%
 
 
 
 
Operating expenses:
 
 
 
General and administrative
31,881

 
27,607

Sales and marketing
13,446

 
12,440

Credit loss expense
6,020

 
5,148

Research and development
3,568

 
3,333

Other charges
2,084

 
3,070

Total operating expenses
56,999

 
51,598

 
 
 
 
Income from operations
13,509

 
13,180

 
 
 
 
Other expense:
 
 
 
Interest expense
(2,107
)
 
(2,482
)
Loss on equity method investments
—

 
(32
)
Other non-operating income/(expense), net
931

 
(1,054
)
Total other expense, net:
(1,176
)
 
(3,568
)
 
 
 
 
Income before income taxes
12,333

 
9,612

(Provision for)/benefit from income taxes
(5,224
)
 
2,073

Net income
$
7,109

 
$
11,685

 
 
 
 
Net income per common share:
 
 
 
Basic
$
0.21

 
$
0.35

Diluted
$
0.19

 
$
0.32

 
 
 
 
Weighted average number of common shares outstanding:
 
 
 
Basic
34,186

 
33,654

Diluted
36,589

 
36,406



beatlogoa07.jpg

BioTelemetry, Inc.
Condensed Consolidated Balance Sheets
 
March 31, 2020
 
December 31,
2019
(in thousands)
 
ASSETS
(unaudited)
 
 
Current assets:
 
 
 
Cash and cash equivalents
$
106,845

 
$
68,614

Healthcare accounts receivable, net
74,864

 
71,851

Other accounts receivable, net
18,727

 
15,625

Inventory
7,612

 
5,738

Prepaid expenses and other current assets
5,026

 
6,505

Total current assets
213,074

 
168,333

 
 
 
 
Property and equipment, net
58,330

 
56,380

Intangible assets, net
125,816

 
129,596

Goodwill
301,150

 
301,321

Deferred tax assets
8,547

 
12,626

Other assets
33,509

 
17,464

Total assets
$
740,426

 
$
685,720

 
 
 
 
LIABILITIES AND EQUITY
 
 
 
Current liabilities:
 
 
 
Accounts payable
25,339

 
24,198

Accrued liabilities
23,379

 
27,318

Current portion of finance lease obligations
373

 
394

Current portion of long-term debt
—

 
3,844

Total current liabilities
49,091

 
55,754

 
 
 
 
Long-term portion of finance lease obligations
272

 
289

Long-term debt
227,425

 
190,823

Other long-term liabilities
86,640

 
71,937

Total liabilities
363,428

 
318,803

 
 
 
 
Total equity
376,998

 
366,917

 
 
 
 
Total liabilities and equity
$
740,426

 
$
685,720



beatlogoa07.jpg

BioTelemetry, Inc.
Reconciliation of GAAP to Non-GAAP Financial Measures
Quarterly Non-GAAP Adjusted Net Income and Non-GAAP Adjusted Net Income Per Share
 
 
Three Months Ended
(Unaudited)
 
March 31, 2020
(in thousands, except per share data)
 
Income from operations
 
Income before income taxes
 
Net income
 
Net income per diluted share
GAAP
 
$
13,509

 
$
12,333

 
$
7,109

 
$
0.19

Non-GAAP adjustments:
 
 
 
 
 
 
 
 
Other charges (a)
 
2,084

 
2,084

 
2,084

 
0.06

Acquisition amortization (b)
 
3,728

 
3,728

 
3,728

 
0.10

Other expense adjustments (c)
 
—

 
(532
)
 
(532
)
 
(0.01
)
Income tax effect of adjustments (d)
 
—

 
—

 
(2,202
)
 
(0.06
)
Impact of NOL utilization (e)
 
—

 
—

 
6,198

 
0.17

Non-GAAP Adjusted
 
$
19,321

 
$
17,613

 
$
16,385

 
$
0.45


 
 
Three Months Ended
(Unaudited)
 
March 31, 2019
(in thousands, except per share data)
 
Income from operations
 
Income before income taxes
 
Net income
 
Net income per diluted share
GAAP
 
$
13,180

 
$
9,612

 
$
11,685

 
$
0.32

Non-GAAP adjustments:
 
 
 
 
 
 
 
 
Other charges (a)
 
3,070

 
3,070

 
3,070

 
0.08

Acquisition amortization (b)
 
3,262

 
3,262

 
3,262

 
0.09

Income tax effect of adjustments (d)
 
—

 
—

 
(1,212
)
 
(0.03
)
(Benefit) of discrete items / NOL utilization (e)
 
—

 
—

 
(1,596
)
 
(0.04
)
Non-GAAP Adjusted
 
$
19,512

 
$
15,944

 
$
15,209

 
$
0.42


a.
In the first quarter 2020, other charges of $2.1 million were primarily due to $1.9 million for patent and other litigation and $0.7 million of integration and other non-recurring charges, offset partially by a $0.3 million favorable change in the fair value of acquisition-related contingent consideration and a $0.3 million net credit from insurance proceeds related to our October 2019 information technology incident. In the first quarter 2019, other charges of $3.1 million were primarily due to $1.9 million for integration and restructuring activities related to our acquisitions and $1.0 million for patent and other litigation.

b.
In the first quarter 2020 and 2019, we recognized $3.7 million and $3.3 million of expense, respectively, related to the amortization of acquisition-related intangibles assets. We have excluded this amortization of acquisition-related intangible assets from non-GAAP adjusted net income due to the non-operational nature of the expense. This amortization was recorded as a component of general and administrative expense.

c.
In the first quarter 2020, we had an unrealized foreign exchange gain of $1.0 million and incurred $0.4 million of interest expense related to a portion of the Geneva Healthcare deferred purchase consideration.

d.
Represents the tax effect of the non-GAAP adjustments at the Company’s annual effective tax rate.

e.
After giving effect to taxes at the estimated annual effective tax rate on the adjustments, the utilization of net operating loss carryforwards and exclusion of discrete items had a $6.2 million positive and a $1.6 million negative impact on the first quarter 2020 and 2019, respectively.



beatlogoa07.jpg

BioTelemetry, Inc.
Reconciliation of GAAP to Non-GAAP Financial Measures
Quarterly Non-GAAP Adjusted EBITDA and EBITDA Margin

(Unaudited)
 
Three Months Ended
 
 
March 31,
(in thousands)
 
2020
 
2019
Net income - GAAP
 
$
7,109

 
$
11,685

Provision for/(benefit from) income taxes
 
5,224

 
(2,073
)
Total other expense, net
 
1,176

 
3,568

Other charges
 
2,084

 
3,070

Depreciation and amortization expense
 
10,485

 
10,021

Stock compensation expense
 
3,382

 
2,549

Non-GAAP Adjusted EBITDA
 
$
29,460

 
$
28,820

GAAP Net income as a percentage of revenue
 
6.3
%
 
11.2
%
Non-GAAP Adjusted EBITDA margin
 
26.1
%
 
27.7
%



Quarterly Non-GAAP Free Cash Flow

(Unaudited)
 
Three Months Ended
 
 
March 31,
(in thousands)
 
2020
 
2019
Cash provided by operating activities
 
$
12,703

 
$
17,544

Capital expenditures
 
(6,984
)
 
(5,334
)
Non-GAAP Free Cash Flow
 
$
5,719

 
$
12,210



Use of Non-GAAP Financial Measures

In addition to the results prepared in accordance with generally accepted accounting principles in the United States (“GAAP”), this press release also includes certain financial measures which have been adjusted and are not in accordance with generally accepted accounting principles (“Non-GAAP financial measures”). These Non-GAAP financial measures include adjusted income from operations, adjusted income before income taxes, adjusted net income, adjusted net income per diluted share, adjusted EBITDA and free cash flow. In accordance with Regulation G of the Securities and Exchange Commission, we have provided a reconciliation of these Non-GAAP financial measures with the most directly comparable financial measure calculated in accordance with GAAP.

These Non-GAAP financial measures are not intended to replace GAAP financial measures. They are presented as supplemental measures of our performance in an effort to provide our stakeholders better visibility into our ongoing operating results and to allow for comparability to prior periods as well as to other companies’ results. Management uses these Non-GAAP financial measures to assess the financial health of our ongoing operating performance. Management encourages our stakeholders to consider all of our financial measures and to not rely on any single financial measure to evaluate our performance.

Adjusted net income for the first quarter 2020 excludes other charges of $2.1 million, $3.7 million of amortization expense related to our acquisition-related intangible assets, $1.0 million of unrealized foreign currency gain, $0.4 million of interest expense related to a portion of the Geneva Healthcare

beatlogoa07.jpg

deferred purchase consideration, the tax effect of these adjustments, as well as the impact from the utilization of our net operating loss carryforwards. Adjusted net income for the first quarter 2019 excludes other charges of $3.1 million, $3.3 million of amortization expense related to acquired intangibles, the tax effect of these adjustments, as well as the exclusion of the benefit of discrete tax items. By excluding expenses that are considered unnecessary to support the ongoing business, are nonrecurring in nature or which limit year over year comparability, we believe these Non-GAAP financial measures offer a meaningful representation of our ongoing operating performance. Included in these excluded items are transaction related expenses, primarily legal and professional fees, integration related expenses, primarily severance, patent and other litigation, amortization of acquired intangibles, costs related to the October 2019 information technology incident net of insurance proceeds, costs related to restructuring programs aimed at streamlining operations and reducing future expense, as well as other one-time items. These excluded charges are not part of the ongoing operations, and therefore, not reflective of our core operations. We view patent litigation as an extreme measure not typically required in our industry to protect a company’s intellectual property and which has not been common practice for us. We commenced patent litigation proceedings after we uncovered specific evidence of four distinct cases of misappropriation and infringement. We can choose to resolve the outstanding matters and terminate the expense at any time. We also included the income tax effect of these adjustments.

In addition to adjusted income from operations, adjusted income before income taxes, adjusted net income, adjusted net income per diluted share and free cash flow, we also present adjusted EBITDA. This Non-GAAP financial measure excludes income taxes, total other expense, net, other charges, depreciation and amortization and stock compensation expense. EBITDA is a widely accepted financial measure which we believe our stakeholders use to compare our ongoing financial performance to that of other companies. Adjusting our EBITDA for other charges and other one-time items is a meaningful financial measure as we believe it is an indication of our ongoing operations. In addition, we also add back stock-based compensation expense because it is non-cash in nature. Other companies may calculate adjusted EBITDA in a different manner.


 EX-101.SCH 3 beat-20200506.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001000 - Document - Cover Document link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 4 beat-20200506_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 5 beat-20200506_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 6 beat-20200506_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Cover [Abstract] Entity Central Index Key Entity Central Index Key Title of 12(g) Security Title of 12(g) Security Entity Address, Address Line One Entity Address, Address Line One Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Document Type Document Type Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, City or Town Entity Address, City or Town Entity Address, State or Province Entity Address, State or Province Entity Address, Postal Zip Code Entity Address, Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Pre-commencement Tender Offer Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Entity Emerging Growth Company Entity Emerging Growth Company Amendment Flag Amendment Flag EX-101.PRE 7 beat-20200506_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 8 beatlogoa07.jpg begin 644 beatlogoa07.jpg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end GRAPHIC 9 beatlogoa08.jpg begin 644 beatlogoa08.jpg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end GRAPHIC 10 logo1a05.jpg BEAT LOGO begin 644 logo1a05.jpg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end XML 11 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.1 html 1 95 1 false 0 0 false 0 false false R1.htm 0001000 - Document - Cover Document Sheet http://www.cardionet.com/role/CoverDocument Cover Document Cover 1 false false All Reports Book All Reports beat56208k.htm beat-20200506.xsd beat-20200506_cal.xml beat-20200506_def.xml beat-20200506_lab.xml beat-20200506_pre.xml beat56208kex991.htm logo1a05.jpg http://xbrl.sec.gov/dei/2019-01-31 true true EXCEL 13 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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htm IDEA: XBRL DOCUMENT v3.20.1
Cover Document
May 06, 2020
Cover [Abstract]  
Entity Central Index Key 0001574774
Title of 12(g) Security Common Stock, par value $0.001 per share
Entity Address, Address Line One 1000 Cedar Hollow Road
Entity Incorporation, State or Country Code DE
Document Type 8-K
Document Period End Date May 06, 2020
Entity Registrant Name BioTelemetry, Inc.
Entity File Number 000-55039
Entity Tax Identification Number 46-2568498
Entity Address, City or Town Malvern,
Entity Address, State or Province PA
Entity Address, Postal Zip Code 19355
City Area Code 610
Local Phone Number 729-7000
Written Communications false
Soliciting Material false
Trading Symbol BEAT
Security Exchange Name NASDAQ
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Amendment Flag false
XML 16 beat56208k_htm.xml IDEA: XBRL DOCUMENT 0001574774 2020-05-06 2020-05-06 false 0001574774 8-K 2020-05-06 BioTelemetry, Inc. DE 000-55039 46-2568498 1000 Cedar Hollow Road Malvern, PA 19355 610 729-7000 false false false false Common Stock, par value $0.001 per share BEAT NASDAQ false JSON 17 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "beat56208k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "calculationLink": { "local": [ "beat-20200506_cal.xml" ] }, "definitionLink": { "local": [ "beat-20200506_def.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml", "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml" ] }, "inline": { "local": [ "beat56208k.htm" ] }, "labelLink": { "local": [ "beat-20200506_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "beat-20200506_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml" ] }, "schema": { "local": [ "beat-20200506.xsd" ], "remote": [ "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd", "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "https://xbrl.sec.gov/exch/2020/exch-2020-01-31.xsd", "http://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd", "https://xbrl.sec.gov/sic/2020/sic-2020-01-31.xsd", "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 23, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2019-01-31": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 95, "memberCustom": 0, "memberStandard": 0, "nsprefix": "beat", "nsuri": "http://www.cardionet.com/20200506", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "beat56208k.htm", "contextRef": "D2020Q1Q120ER", "decimals": null, "first": true, "lang": "en-US", "name": "dei:Security12gTitle", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001000 - Document - Cover Document", "role": "http://www.cardionet.com/role/CoverDocument", "shortName": "Cover Document", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "beat56208k.htm", "contextRef": "D2020Q1Q120ER", "decimals": null, "first": true, "lang": "en-US", "name": "dei:Security12gTitle", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.cardionet.com/role/CoverDocument" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.cardionet.com/role/CoverDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.cardionet.com/role/CoverDocument" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.cardionet.com/role/CoverDocument" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.cardionet.com/role/CoverDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.cardionet.com/role/CoverDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.cardionet.com/role/CoverDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.cardionet.com/role/CoverDocument" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.cardionet.com/role/CoverDocument" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.cardionet.com/role/CoverDocument" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.cardionet.com/role/CoverDocument" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.cardionet.com/role/CoverDocument" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.cardionet.com/role/CoverDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.cardionet.com/role/CoverDocument" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.cardionet.com/role/CoverDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.cardionet.com/role/CoverDocument" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.cardionet.com/role/CoverDocument" ], "xbrltype": "booleanItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r1" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security", "terseLabel": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.cardionet.com/role/CoverDocument" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r0" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.cardionet.com/role/CoverDocument" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.cardionet.com/role/CoverDocument" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.cardionet.com/role/CoverDocument" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.cardionet.com/role/CoverDocument" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } XML 18 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } ZIP 19 0001574774-20-000045-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001574774-20-000045-xbrl.zip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end